Skip to main content

Published locations for 60 weeks of ixekizumab effective, well tolerated in moderate-to-severe plaque psoriasis

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. 60 weeks of ixekizumab effective, well tolerated in moderate-to-severe plaque psoriasis

User login

  • Reset your password
  • /content/60-weeks-ixekizumab-effective-well-tolerated-moderate-severe-plaque-psoriasis
  • /edermatologynews/article/107270/psoriasis/60-weeks-ixekizumab-effective-well-tolerated-moderate
  • /rheumatologynews/article/107270/psoriasis/60-weeks-ixekizumab-effective-well-tolerated-moderate
  • /rheumatology/article/107270/psoriasis/60-weeks-ixekizumab-effective-well-tolerated-moderate-severe
  • /dermatology/article/107270/psoriasis/60-weeks-ixekizumab-effective-well-tolerated-moderate-severe
  • /rheumatology/psoriatic-arthritis-resource-center/article/107270/psoriasis/60-weeks-ixekizumab
  • /dermatology/psoriasiscollection/article/107270/psoriasis/60-weeks-ixekizumab-effective-well
  • /psoriatic-arthritis-icymi/article/107270/psoriasis/60-weeks-ixekizumab-effective-well-tolerated